HK Stock MarketDetailed Quotes

06978 IMMUNOTECH-B

Watchlist
  • 3.360
  • -0.010-0.30%
Trading Apr 26 11:40 CST
1.73BMarket Cap-4679P/E (TTM)

IMMUNOTECH-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Operating income
Operating expenses
Gross profit
Administrative expenses
45.53%-53.22M
45.87%-25.04M
6.28%-97.71M
-9.73%-46.25M
-51.92%-104.25M
-54.71%-42.15M
-147.21%-68.63M
-122.42%-27.25M
-137.96%-27.76M
-156.60%-12.25M
Research and development expenses
-0.63%-177.33M
25.73%-74.32M
26.76%-176.22M
6.77%-100.06M
13.64%-240.61M
-13.02%-107.32M
-349.58%-278.63M
-306.07%-94.96M
-98.82%-61.98M
-106.86%-23.38M
Revaluation surplus
----
----
----
----
----
----
-544.03%-16.98M
-4,929.79%-19.42M
--3.83M
---386K
-Changes in the fair value of other assets
----
----
----
----
----
----
-544.03%-16.98M
-4,929.79%-19.42M
--3.83M
---386K
Special items of operating profit
-134.98%-96.41M
-306.38%-14.88M
-575.60%-41.03M
113.76%7.21M
91.62%-6.07M
110.77%3.37M
-244.05%-72.51M
-132.54%-31.33M
-331.96%-21.07M
-477.21%-13.47M
Operating profit
-3.81%-326.96M
17.88%-114.23M
10.25%-314.96M
4.79%-139.1M
19.65%-350.94M
15.52%-146.1M
-308.23%-436.74M
-249.44%-172.95M
-216.96%-106.98M
-295.76%-49.49M
Financing cost
-38.86%-8.52M
-41.12%-4.37M
-66.80%-6.14M
-106.12%-3.1M
-53.96%-3.68M
-34.56%-1.5M
-15.41%-2.39M
-7.51%-1.12M
-82.38%-2.07M
-449.74%-1.04M
Earning before tax
-4.48%-335.48M
16.59%-118.6M
9.45%-321.1M
3.66%-142.2M
19.25%-354.62M
15.20%-147.6M
-302.67%-439.13M
-244.46%-174.07M
-212.58%-109.05M
-259.54%-50.53M
After-tax profit from continuing operations
-4.48%-335.48M
16.59%-118.6M
9.45%-321.1M
3.66%-142.2M
19.25%-354.62M
15.20%-147.6M
-302.67%-439.13M
-244.46%-174.07M
-212.58%-109.05M
-259.54%-50.53M
Earning after tax
-4.48%-335.48M
16.59%-118.6M
9.45%-321.1M
3.66%-142.2M
19.25%-354.62M
15.20%-147.6M
-302.67%-439.13M
-244.46%-174.07M
-212.58%-109.05M
-259.54%-50.53M
Minority profit
77.90%-660K
73.90%-488K
-663.68%-2.99M
-507.14%-1.87M
-376.83%-391K
-541.67%-308K
67.59%-82K
45.45%-48K
-107.38%-253K
-417.65%-88K
Profit attributable to shareholders
-5.25%-334.82M
15.83%-118.11M
10.20%-318.11M
4.73%-140.33M
19.32%-354.22M
15.36%-147.3M
-303.53%-439.05M
-244.97%-174.02M
-212.95%-108.8M
-259.35%-50.45M
Basic earnings per share
-4.84%-0.65
14.81%-0.23
10.14%-0.62
6.90%-0.27
30.30%-0.69
36.96%-0.29
-241.38%-0.99
-253.85%-0.46
-163.64%-0.29
-160.00%-0.13
Diluted earnings per share
-4.84%-0.65
14.81%-0.23
10.14%-0.62
6.90%-0.27
30.30%-0.69
36.96%-0.29
-241.38%-0.99
-253.85%-0.46
-0.29
-0.13
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Operating income
Operating expenses
Gross profit
Administrative expenses 45.53%-53.22M45.87%-25.04M6.28%-97.71M-9.73%-46.25M-51.92%-104.25M-54.71%-42.15M-147.21%-68.63M-122.42%-27.25M-137.96%-27.76M-156.60%-12.25M
Research and development expenses -0.63%-177.33M25.73%-74.32M26.76%-176.22M6.77%-100.06M13.64%-240.61M-13.02%-107.32M-349.58%-278.63M-306.07%-94.96M-98.82%-61.98M-106.86%-23.38M
Revaluation surplus -------------------------544.03%-16.98M-4,929.79%-19.42M--3.83M---386K
-Changes in the fair value of other assets -------------------------544.03%-16.98M-4,929.79%-19.42M--3.83M---386K
Special items of operating profit -134.98%-96.41M-306.38%-14.88M-575.60%-41.03M113.76%7.21M91.62%-6.07M110.77%3.37M-244.05%-72.51M-132.54%-31.33M-331.96%-21.07M-477.21%-13.47M
Operating profit -3.81%-326.96M17.88%-114.23M10.25%-314.96M4.79%-139.1M19.65%-350.94M15.52%-146.1M-308.23%-436.74M-249.44%-172.95M-216.96%-106.98M-295.76%-49.49M
Financing cost -38.86%-8.52M-41.12%-4.37M-66.80%-6.14M-106.12%-3.1M-53.96%-3.68M-34.56%-1.5M-15.41%-2.39M-7.51%-1.12M-82.38%-2.07M-449.74%-1.04M
Earning before tax -4.48%-335.48M16.59%-118.6M9.45%-321.1M3.66%-142.2M19.25%-354.62M15.20%-147.6M-302.67%-439.13M-244.46%-174.07M-212.58%-109.05M-259.54%-50.53M
After-tax profit from continuing operations -4.48%-335.48M16.59%-118.6M9.45%-321.1M3.66%-142.2M19.25%-354.62M15.20%-147.6M-302.67%-439.13M-244.46%-174.07M-212.58%-109.05M-259.54%-50.53M
Earning after tax -4.48%-335.48M16.59%-118.6M9.45%-321.1M3.66%-142.2M19.25%-354.62M15.20%-147.6M-302.67%-439.13M-244.46%-174.07M-212.58%-109.05M-259.54%-50.53M
Minority profit 77.90%-660K73.90%-488K-663.68%-2.99M-507.14%-1.87M-376.83%-391K-541.67%-308K67.59%-82K45.45%-48K-107.38%-253K-417.65%-88K
Profit attributable to shareholders -5.25%-334.82M15.83%-118.11M10.20%-318.11M4.73%-140.33M19.32%-354.22M15.36%-147.3M-303.53%-439.05M-244.97%-174.02M-212.95%-108.8M-259.35%-50.45M
Basic earnings per share -4.84%-0.6514.81%-0.2310.14%-0.626.90%-0.2730.30%-0.6936.96%-0.29-241.38%-0.99-253.85%-0.46-163.64%-0.29-160.00%-0.13
Diluted earnings per share -4.84%-0.6514.81%-0.2310.14%-0.626.90%-0.2730.30%-0.6936.96%-0.29-241.38%-0.99-253.85%-0.46-0.29-0.13
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg